MARC Record from Library of Congress

LEADER: 03962cam a2200421 i 4500
001 2014430905
003 DLC
005 20141224081717.0
008 141212t20142014enk b 000 0 eng c
010 $a 2014430905
015 $aGBB472559$2bnb
016 7 $a016784997$2Uk
020 $a9781780682471 (paperback)
020 $a1780682476 (paperback)
035 $a(OCoLC)ocn881214970
040 $aERASA$beng$cERASA$erda$dUKMGB$dQGK$dPLL$dOCLCO$dCHVBK$dYDXCP$dUAB$dYLS$dGWL$dRCJ$dPUL$dDLC
042 $apcc
050 00 $aK3260.3$b.S45 2014
100 1 $aSellin, Jennifer Anna,$eauthor.
245 10 $aAccess to medicines :$bthe interface of patents and human rights : does one size fit all? /$cJennifer Anna Sellin.
264 1 $aCambridge, United Kingdom :$bIntersentia Publishing Ltd.,$c[2014]
264 4 $c©2014
300 $axvi, 493 pages ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aSchool of Human Rights research series ;$vvolume 64
500 $aOriginally presented as the author's thesis (Ph.D.)--Universiteit Maastricht, 2014.
504 $aIncludes bibliographical references (pages 461-490).
520 8 $a"Millions of people worldwide lack adequate access to medicines, particularly in developing countries where resources are scarce with devastating human, social and economic consequences. The example of HIV/AIDS, for which treatment has advanced so significantly in the last decade that a diagnosis no longer necessarily brings with it a death sentence, highlights the importance of ensuring that essential medicines are affordable and accessible to all. This book focuses on one aspect of access to medicines: the affordability of essential medicines, and its connection to human rights and patents. The argument often made is that patent protection for medicines results in higher prices which negatively impacts access. Patients having no or inadequate access to affordable medicines endangers the full realisation of human rights, particularly the right to health. This book investigates this issue from a legal perspective, taking both an international and domestic angle. This study examines the interface of access to affordable medicines and patent protection from the perspective of international human rights law and the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) within the framework of the World Trade Organisation. The essential question posed by this book is whether access to medicines and patent protection conflict or coexist. The discussion is deepened by including a developing country approach. Three country studies have been conducted, on South Africa, India and Uganda. These aim to provide a concrete insight into whether these countries recognise and acknowledge the interplay between patents and human rights with respect to access to medicines. Secondly these studies examine whether TRIPS leaves sufficient freedom for (developing) states to adopt a patent system suited to their domestic needs, enabling them to strike a fair balance between access to medicines and patent protection for medicines. In other words: does one size fit all?"--Back cover.
505 00 $tIntroduction & methodology --$tAccess to medicines : the problem --$tA human right of access to medicines? --$tThe TRIPS Agreement : patent protection for pharmaceuticals --$tThe interface between patents and human rights in the context of access to medicines --$tAccess to medicines in South Africa --$tAccess to medicines in India --$tAccess to medicines in Uganda --$tFindings, conclusions and recommendations.
650 0 $aRight to health.
650 0 $aPharmaceutical policy.
650 0 $aMedical care, Cost of$xLaw and legislation.
650 0 $aHuman rights.
650 0 $aDrugs$xPatents.
650 0 $aPatents (International law)
830 0 $aSchool of Human Rights Research series ;$vvolume 64.